Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![neonaveed Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2181427353.png) MNAMD [@neonaveed](/creator/twitter/neonaveed) on x XXX followers
Created: 2025-07-21 11:40:03 UTC

$XBI $IBB

#BIOTECH #SECTOR
 
OLDIES
$AMGN
$BIIB
$GILD
$VRTX
$REGN

NEWBIES
$CRSP 
$MRNA
$BEAM
$IOVA
$FATE
$ADCT

• Biotechs ( $XBI ) have been lagging since the April 2025 rally, underperforming relative to most sectors. However, that trend may be shifting — XBI just reclaimed its 200-day EMA for the first time since the Q1 correction.

• Price is now hovering just above $88, a key level based on the Visible Range Volume Profile (VRVP). This zone marks a potential low-volume pocket up to $XX.

• The move through the XXX EMA is notable, but what stood out even more was yesterday’s candle, which sustained above the XXX EMA with a clean intraday retest — a signal of strength, not noise.

• What to Watch: If XBI can hold above $XX and push into the low-volume zone, it opens the door for a momentum move toward $XX. Keep an eye on leading biotech names that may start rotating back into favor.

![](https://pbs.twimg.com/media/GwYO5yqXMAASNys.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947260278703554715/c:line.svg)

**Related Topics**
[$adct](/topic/$adct)
[$fate](/topic/$fate)
[$regn](/topic/$regn)
[$vrtx](/topic/$vrtx)
[$gild](/topic/$gild)
[$biib](/topic/$biib)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)

[Post Link](https://x.com/neonaveed/status/1947260278703554715)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

neonaveed Avatar MNAMD @neonaveed on x XXX followers Created: 2025-07-21 11:40:03 UTC

$XBI $IBB

#BIOTECH #SECTOR

OLDIES $AMGN $BIIB $GILD $VRTX $REGN

NEWBIES $CRSP $MRNA $BEAM $IOVA $FATE $ADCT

• Biotechs ( $XBI ) have been lagging since the April 2025 rally, underperforming relative to most sectors. However, that trend may be shifting — XBI just reclaimed its 200-day EMA for the first time since the Q1 correction.

• Price is now hovering just above $88, a key level based on the Visible Range Volume Profile (VRVP). This zone marks a potential low-volume pocket up to $XX.

• The move through the XXX EMA is notable, but what stood out even more was yesterday’s candle, which sustained above the XXX EMA with a clean intraday retest — a signal of strength, not noise.

• What to Watch: If XBI can hold above $XX and push into the low-volume zone, it opens the door for a momentum move toward $XX. Keep an eye on leading biotech names that may start rotating back into favor.

XXX engagements

Engagements Line Chart

Related Topics $adct $fate $regn $vrtx $gild $biib $ibb $xbi

Post Link

post/tweet::1947260278703554715
/post/tweet::1947260278703554715